Patients | Overall surviva | Cancer-specific survival | |||
---|---|---|---|---|---|
3 year | 5 year | 3 year | 5 year | ||
Training cohort | Nomogram | 0.836 | 0.845 | 0.822 | 0.838 |
FIGO stage | 0.769 | 0.771 | 0.758 | 0.769 | |
Internal validation cohort | Nomogram | 0.861 | 0.854 | 0.875 | 0.877 |
FIGO stage | 0.773 | 0.760 | 0.793 | 0.789 | |
External validation cohort | Nomogram | 0.832 | 0.833 | 0.827 | 0.826 |
FIGO stage | 0.770 | 0,774 | 0.791 | 0.786 |